Development and clinical application of new polyvalent combined paediatric vaccines
- 1 January 1999
- Vol. 17 (13-14) , 1620-1627
- https://doi.org/10.1016/s0264-410x(98)00426-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vaccination and its adverse effects: real or perceivedBMJ, 1998
- Immunogenicity of a combined Diphtheria-Tetanus-Acellular Pertussis(DT-tricomponent Pa)-Hepatitis B (HB)-Inactivated Poliovirus (IPV) admixed with Haemophilus influenzae type b (Hib) Vaccine in Infants♦ 813Pediatric Research, 1998
- A Randomized Study of the Safety and Immunogenicity of DTPa-HB-IPV Vaccine Administered as Three Doses or in a Sequential IPV/OPV Schedule at 2, 4, and 6 Months of Age ♦ 933Pediatric Research, 1998
- Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccineThe Pediatric Infectious Disease Journal, 1997
- Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: Immunogenicity and reactogenicity profilesInternational Journal of Infectious Diseases, 1997
- Overview Of The Clinical Development Of A Diphtheria-Tetanus-Acellular Pertussis VaccineThe Journal of Infectious Diseases, 1996
- Report of the Expert Panel VIII New vaccines, especially new combined vaccinesVaccine, 1996
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination scheduleVaccine, 1995
- Development of Combined Vaccines: Manufacturers' ViewpointBiologicals, 1994